Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

  1. De Laurentiis, M.
  2. Borstnar, S.
  3. Campone, M.
  4. Warner, E.
  5. Bofill, J.S.
  6. Jacot, W.
  7. Dent, S.
  8. Martin, M.
  9. Ring, A.
  10. Cottu, P.
  11. Lu, J.
  12. Ciruelos, E.
  13. Azim, H.A.
  14. Chatterjee, S.
  15. Zhou, K.
  16. Wu, J.
  17. Menon-Singh, L.
  18. Zamagni, C.
Zeitschrift:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Datum der Publikation: 2021

Ausgabe: 189

Nummer: 3

Seiten: 689-699

Art: Artikel

DOI: 10.1007/S10549-021-06334-0 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus